Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Fast and stable vapochromic response induced through nanocrystal formation of a luminescent platinum(II) complex on periodic mesoporous organosilica.

Matsukawa H, Yoshida M, Tsunenari T, Nozawa S, Sato-Tomita A, Maegawa Y, Inagaki S, Kobayashi A, Kato M.

Sci Rep. 2019 Oct 22;9(1):15151. doi: 10.1038/s41598-019-51615-w.

2.

Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974.

Shiraiwa H, Narita A, Kamata-Sakurai M, Ishiguro T, Sano Y, Hironiwa N, Tsushima T, Segawa H, Tsunenari T, Ikeda Y, Kayukawa Y, Noguchi M, Wakabayashi T, Sakamoto A, Konishi H, Kuramochi T, Endo M, Hattori K, Nezu J, Igawa T.

Methods. 2019 Feb 1;154:10-20. doi: 10.1016/j.ymeth.2018.10.005. Epub 2018 Oct 13.

PMID:
30326272
3.

[A Curatively Resected Case of Lateral Lymph Node Metastasis Five-Years after Initial Surgery for Rectal Cancer].

Miura T, Tsunenari T, Sasaki T, Yokoyama T, Fukuhara K.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1405-1407. Japanese.

PMID:
29394649
4.

An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors.

Ishiguro T, Sano Y, Komatsu SI, Kamata-Sakurai M, Kaneko A, Kinoshita Y, Shiraiwa H, Azuma Y, Tsunenari T, Kayukawa Y, Sonobe Y, Ono N, Sakata K, Fujii T, Miyazaki Y, Noguchi M, Endo M, Harada A, Frings W, Fujii E, Nanba E, Narita A, Sakamoto A, Wakabayashi T, Konishi H, Segawa H, Igawa T, Tsushima T, Mutoh H, Nishito Y, Takahashi M, Stewart L, ElGabry E, Kawabe Y, Ishigai M, Chiba S, Aoki M, Hattori K, Nezu J.

Sci Transl Med. 2017 Oct 4;9(410). pii: eaal4291. doi: 10.1126/scitranslmed.aal4291.

PMID:
28978751
5.

Aromatherapies using Osmanthus fragrans oil and grapefruit oil are effective complementary treatments for anxious patients undergoing colonoscopy: A randomized controlled study.

Hozumi H, Hasegawa S, Tsunenari T, Sanpei N, Arashina Y, Takahashi K, Konnno A, Chida E, Tomimatsu S.

Complement Ther Med. 2017 Oct;34:165-169. doi: 10.1016/j.ctim.2017.08.012. Epub 2017 Aug 24.

PMID:
28917370
6.

Synchronous neuroendocrine tumors in both the pancreas and ileum: A case report.

Tsunenari T, Aosasa S, Ogata S, Hoshikawa M, Nishikawa M, Noro T, Shinto E, Tsujimoto H, Ueno H, Hamabe F, Shinmoto H, Hase K, Yamamoto J.

Int J Surg Case Rep. 2016;22:47-50. doi: 10.1016/j.ijscr.2016.03.028. Epub 2016 Mar 24.

7.

CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.

Ishikura N, Kawata H, Nishimoto A, Nakamura R, Tsunenari T, Watanabe M, Tachibana K, Shiraishi T, Yoshino H, Honma A, Emura T, Ohta M, Nakagawa T, Houjo T, Corey E, Vessella RL, Aoki Y, Sato H.

Int J Oncol. 2015 Apr;46(4):1560-72. doi: 10.3892/ijo.2015.2860. Epub 2015 Jan 30.

PMID:
25634071
8.

Variations in signal intensity with periodical temperature changes in vivo in rat brain: analysis using wide-field optical coherence tomography.

Sato M, Nomura D, Kitano T, Tsunenari T, Nishidate I.

Appl Opt. 2012 Apr 1;51(10):1436-45. doi: 10.1364/AO.51.001436.

PMID:
22505060
9.

Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer.

Yoshino H, Sato H, Shiraishi T, Tachibana K, Emura T, Honma A, Ishikura N, Tsunenari T, Watanabe M, Nishimoto A, Nakamura R, Nakagawa T, Ohta M, Takata N, Furumoto K, Kimura K, Kawata H.

Bioorg Med Chem. 2010 Dec 1;18(23):8150-7. doi: 10.1016/j.bmc.2010.10.023. Epub 2010 Oct 15.

PMID:
21050768
10.

In vivo rat brain measurements of changes in signal intensity depth profiles as a function of temperature using wide-field optical coherence tomography.

Sato M, Nomura D, Tsunenari T, Nishidate I.

Appl Opt. 2010 Oct 20;49(30):5686-96. doi: 10.1364/AO.49.005686.

PMID:
20962931
11.

Measurement of signal intensity depth profiles in rat brains with cardiac arrest maintaining primary temperature by wide-field optical coherence tomography.

Sato M, Nomura D, Tsunenari T, Nishidate I.

Appl Opt. 2010 Sep 10;49(26):4851-8. doi: 10.1364/AO.49.004851.

PMID:
20830172
12.

Thiochroman derivative CH4986399, a new nonsteroidal estrogen receptor down-regulator, is effective in breast cancer models.

Yoneya T, Taniguchi K, Nakamura R, Tsunenari T, Ohizumi I, Kanbe Y, Morikawa K, Kaiho S, Yamada-Okabe H.

Anticancer Res. 2010 Mar;30(3):873-8.

PMID:
20393009
13.

Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity.

Kawata H, Ishikura N, Watanabe M, Nishimoto A, Tsunenari T, Aoki Y.

Prostate. 2010 May 15;70(7):745-54. doi: 10.1002/pros.21107.

PMID:
20058237
14.

Intrinsic light response of retinal horizontal cells of teleosts.

Cheng N, Tsunenari T, Yau KW.

Nature. 2009 Aug 13;460(7257):899-903. doi: 10.1038/nature08175. Epub 2009 Jul 26.

15.

Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels.

Yoneya T, Tsunenari T, Taniguchi K, Kanbe Y, Morikawa K, Yamada-Okabe H, Lee YH, Lee MH, Kwon LS.

Oncol Rep. 2009 Mar;21(3):747-55.

PMID:
19212635
16.

Discovery of an orally-active nonsteroidal androgen receptor pure antagonist and the structure-activity relationships of its derivatives.

Tachibana K, Imaoka I, Shiraishi T, Yoshino H, Nakamura M, Ohta M, Kawata H, Taniguchi K, Ishikura N, Tsunenari T, Saito H, Nagamuta M, Nakagawa T, Takanashi K, Onuma E, Sato H.

Chem Pharm Bull (Tokyo). 2008 Nov;56(11):1555-61. Erratum in: Chem Pharm Bull (Tokyo). 2009 Oct;57(10):1178.

17.

Involvement of cyclooxygenase-2 in the tumor site-dependent production of parathyroid hormone-related protein in colon 26 carcinoma.

Saito H, Inagaki Y, Tsunenari T, Ura M, Mizuno H, Fujimoto-Ouchi K, Onuma E, Sato K, Ogata E, Yamada-Okabe H.

Cancer Sci. 2007 Oct;98(10):1563-9. Epub 2007 Jul 23.

18.

Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma.

Azuma Y, Ishikawa Y, Kawai S, Tsunenari T, Tsunoda H, Igawa T, Iida S, Nanami M, Suzuki M, Irie RF, Tsuchiya M, Yamada-Okabe H.

Clin Cancer Res. 2007 May 1;13(9):2745-50. Erratum in: Clin Cancer Res. 2007 Jul 1;13(13):4029-31.

19.

Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.

Uno S, Kinoshita Y, Azuma Y, Tsunenari T, Yoshimura Y, Iida S, Kikuchi Y, Yamada-Okabe H, Fukushima N.

Oncol Rep. 2007 May;17(5):1189-94.

PMID:
17390064
20.

Newly discovered orally active pure antiestrogens.

Kanbe Y, Kim MH, Nishimoto M, Ohtake Y, Yoneya T, Ohizumi I, Tsunenari T, Taniguchi K, Kaiho S, Nabuchi Y, Araya H, Kawata S, Morikawa K, Jo JC, Kwon HA, Lim HS, Kim HY.

Bioorg Med Chem Lett. 2006 Sep 15;16(18):4959-64. Epub 2006 Jun 27.

PMID:
16806917
21.

Discovery of thiochroman derivatives bearing a carboxy-containing side chain as orally active pure antiestrogens.

Kanbe Y, Kim MH, Nishimoto M, Ohtake Y, Tsunenari T, Taniguchi K, Ohizumi I, Kaiho S, Nabuchi Y, Kawata S, Morikawa K, Jo JC, Kwon HA, Lim HS, Kim HY.

Bioorg Med Chem Lett. 2006 Aug 1;16(15):4090-4. Epub 2006 May 18.

PMID:
16709454
22.

Ca2+-activated Cl- current from human bestrophin-4 in excised membrane patches.

Tsunenari T, Nathans J, Yau KW.

J Gen Physiol. 2006 Jun;127(6):749-54. Epub 2006 May 15.

23.

Aquaporin-11: a channel protein lacking apparent transport function expressed in brain.

Gorelick DA, Praetorius J, Tsunenari T, Nielsen S, Agre P.

BMC Biochem. 2006 May 1;7:14.

24.

Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationship.

Kanbe Y, Kim MH, Nishimoto M, Ohtake Y, Kato N, Tsunenari T, Taniguchi K, Ohizumi I, Kaiho S, Morikawa K, Jo JC, Lim HS, Kim HY.

Bioorg Med Chem. 2006 Jul 15;14(14):4803-19. Epub 2006 Mar 31.

PMID:
16580210
25.

Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.

Saito H, Tsunenari T, Onuma E, Sato K, Ogata E, Yamada-Okabe H.

Anticancer Res. 2005 Nov-Dec;25(6B):3817-23. Erratum in: Anticancer Res. 2006 Jan-Feb;26(1a):445.

26.

Identification of a novel, orally bioavailable estrogen receptor downregulator.

Yoneya T, Taniguchi K, Tsunenari T, Saito H, Kanbe Y, Morikawa K, Yamada-Okabe H.

Anticancer Drugs. 2005 Aug;16(7):751-6.

PMID:
16027525
27.

Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.

Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.

Clin Cancer Res. 2005 Jun 1;11(11):4198-203.

29.

Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.

Onuma E, Sato K, Saito H, Tsunenari T, Ishii K, Esaki K, Yabuta N, Wakahara Y, Yamada-Okabe H, Ogata E.

Anticancer Res. 2004 Sep-Oct;24(5A):2665-73.

30.

Structure-function analysis of the bestrophin family of anion channels.

Tsunenari T, Sun H, Williams J, Cahill H, Smallwood P, Yau KW, Nathans J.

J Biol Chem. 2003 Oct 17;278(42):41114-25. Epub 2003 Aug 7.

31.

The vitelliform macular dystrophy protein defines a new family of chloride channels.

Sun H, Tsunenari T, Yau KW, Nathans J.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):4008-13.

32.

Physiology of morphologically identified cells of the bullfrog fungiform papilla.

Takeuchi H, Tsunenari T, Kurahashi T, Kaneko A.

Neuroreport. 2001 Sep 17;12(13):2957-62.

PMID:
11588610
33.
34.

[Ehlers-Danlos syndrome type IV complicated by intraperitoneal hemorrhage].

Tsunenari T, Ozawa K, Nyuukai K, Yo M, Fujita H, Uesaka K.

Nihon Naika Gakkai Zasshi. 2000 Feb 10;89(2):341-3. Japanese. No abstract available.

PMID:
10756648
35.
36.

Effects of ionic compositions of the medium on monosodium glutamate binding to taste epithelial cells.

Hayashi Y, Tsunenari T, Mori T.

Biosci Biotechnol Biochem. 1999 Mar;63(3):480-4.

37.

Noise analysis of the quinine-induced current in frog taste receptor cells.

Tsunenari T, Kaneko A.

Ann N Y Acad Sci. 1998 Nov 30;855:148-9.

PMID:
9929596
38.

New xenograft model of multiple myeloma and efficacy of a humanized antibody against human interleukin-6 receptor.

Tsunenari T, Koishihara Y, Nakamura A, Moriya M, Ohkawa H, Goto H, Shimazaki C, Nakagawa M, Ohsugi Y, Kishimoto T, Akamatsu K.

Blood. 1997 Sep 15;90(6):2437-44.

PMID:
9310495
39.

Flat revertant inducers, styryl diphenylamine derivatives, inhibit growth and metastasis of murine tumor cells in vivo.

Ohizumi I, Tanemura M, Tsunenari T, Sato K, Kozono T, Kaiho S.

Anticancer Res. 1997 Jan-Feb;17(1A):393-400.

PMID:
9066683
40.

A quinine-activated cationic conductance in vertebrate taste receptor cells.

Tsunenari T, Hayashi Y, Orita M, Kurahashi T, Kaneko A, Mori T.

J Gen Physiol. 1996 Dec;108(6):515-23.

41.

Therapeutic potential of humanized anti-interleukin-6 receptor antibody: antitumor activity in xenograft model of multiple myeloma.

Tsunenari T, Akamatsu K, Kaiho S, Sato K, Tsuchiya M, Koishihara Y, Kishimoto T, Ohsugi Y.

Anticancer Res. 1996 Sep-Oct;16(5A):2537-44.

PMID:
8917348
42.

Relationship between respiratory muscle strength and lean body mass in men with COPD.

Nishimura Y, Tsutsumi M, Nakata H, Tsunenari T, Maeda H, Yokoyama M.

Chest. 1995 May;107(5):1232-6.

PMID:
7750311
43.

Menopause-related changes in bone mineral density in Japanese women: a longitudinal study on lumbar spine and proximal femur.

Tsunenari T, Yamada S, Kawakatsu M, Negishi H, Tsutsumi M.

Calcif Tissue Int. 1995 Jan;56(1):5-10.

PMID:
7796347
44.

Radial bone mineral content of normal Japanese infants and prepubertal children: influence of age, sex and body size.

Sugimoto T, Nishino M, Tsunenari T, Kawakatsu M, Shimogaki K, Fujii Y, Negishi H, Tsutsumi M, Fukase M, Chihara K.

Bone Miner. 1994 Mar;24(3):189-200.

PMID:
8019206
45.

In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.

Akamatsu K, Saito H, Tsunenari T, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.

Anticancer Res. 1993 Nov-Dec;13(6A):2261-5.

PMID:
8297143
46.

Age- and gender-related changes in body composition in Japanese subjects.

Tsunenari T, Tsutsumi M, Ohno K, Yamamoto Y, Kawakatsu M, Shimogaki K, Negishi H, Sugimoto T, Fukase M, Fujita T.

J Bone Miner Res. 1993 Apr;8(4):397-402.

PMID:
8475789
47.

[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].

Akamatsu K, Endo K, Tsunenari T, Matsumoto T, Kaiho S, Morikawa K, Koizumi M, Mitsui H, Koizumi K.

Gan To Kagaku Ryoho. 1992 Feb;19(2):229-35. Japanese.

PMID:
1736835
48.

Bone histomorphometric analysis for the cause of osteopenia in vitamin C-deficient rat (ODS rat).

Tsunenari T, Fukase M, Fujita T.

Calcif Tissue Int. 1991 Jan;48(1):18-27.

PMID:
2007223
49.

Therapeutic trial of hematological disorders with intermittent administration of high-dose 1-alpha-hydroxyvitamin D3.

Imai Y, Tsutsumi M, Tsunenari T, Nishikawa M, Matsui T, Natazuka T, Fujita T.

Contrib Nephrol. 1991;91:95-101.

PMID:
1800016
50.

Quantitative bone histomorphometry and circulating T lymphocyte subsets in postmenopausal osteoporosis.

Imai Y, Tsunenari T, Fukase M, Fujita T.

J Bone Miner Res. 1990 Apr;5(4):393-9.

PMID:
2343779

Supplemental Content

Loading ...
Support Center